|
![]() |
|||
|
||||
OverviewDesigner drugs, or new psychoactive substances (NPS), are synthetic chemicals that mimic the effects of classic drugs of abuse. There has been an alarming worldwide increase in the abuse of NPS in recent years. NPS are cheap, easy to obtain, and often legally available. In this volume, leading experts summarize the latest studies regarding the molecular mechanisms of action, behavioral effects, and adverse consequences of popular NPS. Specific chapters clarify the differences between various types of NPS, namely: stimulants, cannabinoids and hallucinogens. Thus, this volume broadens our understanding of NPS and provides insight into the rapidly evolving “new drug” phenomenon. Full Product DetailsAuthor: Michael H. Baumann , Richard A. Glennon , Jenny L. WileyPublisher: Springer International Publishing AG Imprint: Springer International Publishing AG Edition: Softcover reprint of the original 1st ed. 2017 Volume: 32 Weight: 0.797kg ISBN: 9783319849065ISBN 10: 3319849069 Pages: 380 Publication Date: 18 July 2018 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsThis book brings together an international panel of leading experts to summarize the latest studies regarding the mechanisms of actions, behavioral effects, and adverse consequences of popular `designer drugs.' ... The book is intended to provide useful information to scientists, clinicians, law enforcement agencies, and policymakers who are engaged in the responding to the growing phenomenon of the use of these drugs. (Michael Easton, Doody's Book Reviews, August, 2017) Author Information
Tab Content 6Author Website:Countries AvailableAll regions |